HC Wainwright reiterated their buy rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research report released on Wednesday, MarketBeat reports. HC Wainwright currently has a $20.00 target price on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on ENTA. Wall Street Zen cut shares […]

Telix Pharmaceuticals (NASDAQ:TLX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a report released on Friday, Benzinga reports. They presently have a $20.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 74.98% from the company’s previous close. Several other […]